Health and Medicine
-
September 21, 2017
Pancreatic islets study may spur diabetes treatment advances
Investigators in the Vanderbilt Diabetes Research and Training Center (VDRTC) and collaborators at Stanford University have discovered new insights into the molecular mechanisms of cell proliferation in juvenile human pancreatic islets, information that could lead to new treatments for diabetes. -
September 21, 2017
VUSN names Kleinpell assistant dean for Clinical Scholarship
Ruth Kleinpell, Ph.D., R.N., an internationally recognized nurse researcher, scholar and educator, has joined Vanderbilt University School of Nursing (VUSN) as assistant dean for Clinical Scholarship and professor of Nursing. -
September 20, 2017
Goal of new tissue-chip research is to assess efficacy of novel epilepsy drugs
An interdisciplinary team of Vanderbilt University researchers has received a two-year, $2-million federal grant to develop an “organ-on-chip” model for two genetic forms of epilepsy. -
September 20, 2017
NSAIDs, genetics and miscarriage
A certain genetic variant, in combination with the use of anti-inflammatory drugs like aspirin and ibuprofen during early pregnancy, may protect women from miscarriage. -
September 19, 2017
Medication safety in the ICU
Facilitated reporting of medication-related events in the intensive care unit can provide opportunities for optimizing quality of care and patient safety. -
September 15, 2017
Inhibiting obesity
An enzyme in the gut – NAPE-PLD – is required for the action of signaling molecules that reduce food intake and weight gain. -
September 14, 2017
Acid reflux cancer link
Blocking acid reflux-induced production of reactive oxygen compounds may be a useful strategy for preventing DNA damage and decreasing the risk of esophageal cancer.